Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Natasha L. Martin"'
Autor:
Robert A. Livingston, Myron J. Levin, Ann Marie Duliege, Gale Smith, Thomas C. VanCott, Elizabeth Hawkins, Diane W. Wara, Daniel Johnson, George McSherry, John S. Lambert, William Borkowsky, Donald P. Francis, Ram Yogev, Jack Moye, Minhee Kang, James McNamara, Terry Fenton, Natasha L. Martin, Samuel L. Katz, Anne A. Gershon
Publikováno v:
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 19:451-461
Study objectives were to evaluate the safety and immunogenicity of three HIV recombinant glycoproteins in HIV-infected infants and children between 1 month and 18 years of age with asymptomatic (P-1) infection. Using Chiron rgp 120 (SF-2) 15 or 50 mi
Publikováno v:
Annals of the New York Academy of Sciences. 693:14-19
Autor:
Natasha L. Martin, Yolanda Rooks, William C. Mentzer, Jukka Rautonen, Nina Rautonen, Diane W. Wara
Publikováno v:
Immunology Letters. 34:207-211
B cell function is impaired in patients with sickle cell anemia. Although the number of surface IgM positive cells was similar in sickle cell patients and controls, in vitro spontaneous IgM, and PWM stimulated IgA, IgM, and IgG synthesis was signific
Publikováno v:
Immunological Investigations. 21:65-70
A simple dot blot screening test for anti-HIV-1 IgA in infant sera was developed using recombinant HIV proteins. Ten control infants, 19 uninfected infants of seropositive mothers and 12 HIV culture positive infants were studied at 3 month and 18 mon
Autor:
Jay A. Levy, Morton J. Cowan, Peggy S. Weintrub, Harold Legg, Natasha L. Martin, Diane W. Wara
Publikováno v:
The Journal of Pediatrics. 118:354-358
To diagnose infection with the human immunodeficiency virus (HIV) soon after birth in infants born to HIV type 1-infected women, we developed antiviral IgA Western blot and dot blot assays with recombinant HIV-1 proteins. Thirty-three infants born to
Publikováno v:
AIDS Research and Human Retroviruses. 13:905-907
Autor:
Mary Ann Fletcher, Roberto Patarca, Natasha L. Martin, Nancy G. Klimas, Gwendolyn B. Scott, Kevin Maher, Cecelia Hutto, Dmitry Sandler
Publikováno v:
AIDS research and human retroviruses. 12(11)
Pediatric slow progressors are a group of HIV-1-infected individuals who are homogeneous for route and length of infection and standard of care and are therefore amenable to cross-sectional population studies on the immunological correlates of diseas
Publikováno v:
AIDS research and human retroviruses. 10(7)
Tat is a potent trans-activating protein encoded by the HIV genome. It is essential for viral replication, but has pleiotropic effects on host cells as well. We demonstrated that exogenous recombinant Tat increases immunoglobulin (Ig) and interleukin
Autor:
Su Chun Cheng, Jukka Rautonen, Natasha L. Martin, Leila Siller, Laurel A. Beckett, Diane W. Wara, Paul Kostuchenko
Publikováno v:
AIDS (London, England). 7(3)
Objective To test the hypothesis that serum levels of soluble markers in children change after initiation of zidovudine therapy and that the extent and pattern of these longitudinal changes correlates with clinical outcome. Patients and methods We me
Publikováno v:
AIDS (London, England). 5(11)
Hypergammaglobulinemia is one of the most consistent, and usually the first observable abnormality in infants vertically infected with HIV. We have analyzed serum interleukin (IL)-4, IL-6, tumor necrosis factor (TNF)-alpha, and immunoglobulin (Ig) co